ACI/Eur |
body weight |
right nephrectomy |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168 days-175 days |
12 |
315.0 |
g |
3.0 |
10.39 |
body weighing method |
|
|
0 |
|
11930 |
62 |
WKY/NCruk |
body weight |
left nephrectomy and left kidney transplant then right nephrectomy |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
body mass |
male |
175 days
| 20 |
338.8 |
g |
5.95 |
26.6 |
body weighing method |
0.0 |
|
0 |
|
67747 |
110 |
MW |
body weight |
right nephrectomy (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 6 |
258.7 |
g |
11.0 |
26.94 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100799 |
2523 |
MW |
body weight |
right nephrectomy (for 84 days) then reserpine (5 mg/l) (for 28 days) and hydralazine (80 mg/l) (for 28 days) and controlled hydralazine content drinking water (25 mg/l) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 10 |
276.6 |
g |
7.4 |
23.4 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100807 |
2523 |
MW |
body weight |
right nephrectomy (for 84 days) then lisinopril (10 mg/kg/d) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 10 |
293.5 |
g |
5.4 |
17.08 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100824 |
2523 |
MW |
body weight |
right nephrectomy (for 84 days) then angiotensin II receptor antagonist (20 mg/l) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 7 |
284.7 |
g |
7.2 |
19.05 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100825 |
2523 |
MW |
body weight |
right nephrectomy (for 56 days) then captopril (30 mg/kg/d) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 10 |
287.2 |
g |
5.4 |
17.08 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100801 |
2523 |
MW |
body weight |
right nephrectomy (for 56 days) then lisinopril (10 mg/kg/d) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 10 |
282.7 |
g |
5.1 |
16.13 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100803 |
2523 |
ACI.FHH-(D1Rat298-D1Rat90)/Eur |
body weight |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168 days-175 days |
12 |
319.0 |
g |
6.0 |
20.78 |
body weighing method |
0.0 |
|
0 |
|
67706 |
62 |
MW |
body weight |
right nephrectomy (for 56 days) then reserpine (5 mg/l) and hydralazine (80 mg/l) and controlled hydralazine content drinking water (25 mg/l) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 10 |
276.6 |
g |
7.4 |
23.4 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100800 |
2523 |
MW |
body weight |
right nephrectomy (for 56 days) then angiotensin II receptor antagonist (20 mg/l) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 7 |
254.9 |
g |
14.1 |
37.31 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100804 |
2523 |
MW |
body weight |
right nephrectomy (for 84 days) then angiotensin II receptor antagonist (80 mg/l) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 5 |
276.4 |
g |
4.9 |
10.96 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100826 |
2523 |
MW |
body weight |
right nephrectomy (for 112 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 6 |
283.2 |
g |
19.9 |
48.74 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100827 |
2523 |
MW |
body weight |
right nephrectomy (for 112 days) then enalapril (20 mg/kg/d) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 9 |
313.8 |
g |
15.0 |
45.0 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100830 |
2523 |
MW |
body weight |
right nephrectomy (for 84 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 6 |
294.0 |
g |
8.2 |
20.09 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100806 |
2523 |
ACI.FHH-(D3Wox2-D3Rat59)/Eur |
body weight |
right nephrectomy |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168 days-175 days |
12 |
311.0 |
g |
4.0 |
13.86 |
body weighing method |
0.0 |
|
0 |
|
11948 |
62 |
MW |
body weight |
right nephrectomy (for 112 days) then angiotensin II receptor antagonist (80 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 5 |
271.0 |
g |
14.1 |
31.53 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100833 |
2523 |
MW |
body weight |
right nephrectomy (for 84 days) then captopril (30 mg/kg/d) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 10 |
290.8 |
g |
8.0 |
25.3 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100822 |
2523 |
ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
body weight |
right nephrectomy |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168 days-175 days |
12 |
304.0 |
g |
5.0 |
17.32 |
body weighing method |
|
|
0 |
|
11953 |
62 |
ACI.FHH-(D3Wox2-D3Rat59)/Eur |
body weight |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168 days-175 days |
11 |
301.0 |
g |
6.0 |
19.9 |
body weighing method |
0.0 |
|
0 |
|
67705 |
62 |
WKY/NCruk |
body weight |
left nephrectomy and left kidney transplant then right nephrectomy |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
body mass |
male |
175 days
| 17 |
335.8 |
g |
7.62 |
31.4 |
body weighing method |
0.0 |
|
0 |
|
67746 |
110 |
MW |
body weight |
right nephrectomy (for 84 days) then enalapril (20 mg/kg/d) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 9 |
299.6 |
g |
11.7 |
35.1 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100823 |
2523 |
MW |
body weight |
right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 10 |
244.3 |
g |
17.2 |
54.39 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100828 |
2523 |
MW |
body weight |
right nephrectomy (for 112 days) then captopril (30 mg/kg/d) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 10 |
320.6 |
g |
15.0 |
47.43 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100829 |
2523 |
MW |
body weight |
right nephrectomy (for 112 days) then lisinopril (10 mg/kg/d) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 10 |
293.0 |
g |
14.2 |
44.9 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100831 |
2523 |
MW |
body weight |
right nephrectomy (for 112 days) then angiotensin II receptor antagonist (20 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 7 |
289.0 |
g |
13.6 |
35.98 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100832 |
2523 |
ACI/Eur |
body weight |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168 days-175 days |
12 |
314.0 |
g |
6.0 |
20.78 |
body weighing method |
0.0 |
|
0 |
|
67704 |
62 |
ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
body weight |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168 days-175 days |
5 |
263.0 |
g |
12.0 |
26.83 |
body weighing method |
0.0 |
|
0 |
|
67707 |
62 |
ACI.FHH-(D1Rat298-D1Rat90)/Eur |
body weight |
right nephrectomy |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168 days-175 days |
12 |
330.0 |
g |
6.0 |
20.78 |
body weighing method |
0.0 |
|
0 |
|
11951 |
62 |
MW |
body weight |
right nephrectomy (for 56 days) then enalapril (20 mg/kg/d) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 9 |
280.5 |
g |
1.1 |
3.3 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100802 |
2523 |
MW |
body weight |
right nephrectomy (for 56 days) then angiotensin II receptor antagonist (80 mg/l) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
body mass |
male |
0 days
| 5 |
257.0 |
g |
6.1 |
13.64 |
body weighing method |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100805 |
2523 |